The Technical Analyst
Select Language :
Materialise NV [MTLS]

Exchange: NASDAQ Sector: Technology Industry: Software—Application

Materialise NV Price, Forecast, Insider, Ratings, Fundamentals & Signals

Materialise NV is listed at the  Exchange

2.19% €5.13

America/New_York / 27 mar 2024 @ 16:00


Materialise NV: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 303.01 mill
EPS: 0.120
P/E: 42.75
Earnings Date: Apr 24, 2024
SharesOutstanding: 59.07 mill
Avg Daily Volume: 0.0876 mill
RATING 2024-03-27
B-
Neutral
RATINGS
Rating CashFlow: Buy
Return On Equity: Sell
Return On Asset: Sell
DE: Neutral
P/E: Strong Sell
Price To Book: Neutral
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 42.75 | sector: PE -1.697
PE RATIO: COMPANY / INDUSTRY
0x
Company: PE 42.75 | industry: PE -81.55
DISCOUNTED CASH FLOW VALUE
€6.02
(17.37%) €0.891
Date: 2024-03-28
Expected Trading Range (DAY)

€ 4.90 - 5.36

( +/- 4.42%)
ATR Model: 14 days

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - €5.13
Forecast 2: 16:00 - €5.13
Forecast 3: 16:00 - €5.13
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price €5.13 (2.19% )
Volume 0.135 mill
Avg. Vol. 0.0876 mill
% of Avg. Vol 154.07 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Materialise NV

Last 12 Months

Last 12 months chart data with high, low, open and close for Materialise NV

RSI

Intraday RSI14 chart for Materialise NV

Last 10 Buy & Sell Signals For MTLS

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Materialise NV

MTLS

Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company's Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Last 10 Buy Signals

Date Signal @
NOD.OLMar 27 - 08:05NOK85.80
SOON.OLMar 27 - 08:05NOK67.00
ELO.OLMar 27 - 08:05NOK34.00
VEI.OLMar 27 - 08:05NOK118.00
RIVER.OLMar 27 - 08:0527.00
MAS.OLMar 27 - 08:0530.30
NAVA.OLMar 27 - 07:58NOK35.60
CARA.OLMar 27 - 08:05NOK11.52
NOL.OLMar 27 - 08:09NOK9.97
OLT.OLMar 27 - 08:05NOK222.00

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.